|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sundar R, Soong R, Cho BC, Brahmer JR and
Soo RA: Immunotherapy in the treatment of non-small cell lung
cancer. Lung Cancer. 85:101–109. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choudhury A, Palma M and Mellstedt H: The
future of cancer vaccines for non-small-cell lung cancer: Ongoing
trials. Clin Lung Cancer. 9(Suppl 1): S37–S44. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sharma A, Moore WH, Lanuti M and Shepard
JA: How I do it: Radiofrequency ablation and cryoablation of lung
tumors. J Thorac Imaging. 26:162–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schiller JH, Harrington D, Belani CP,
Langer C, Sandler A, Krook J, Zhu J and Johnson DH; Eastern
Cooperative Oncology Group: Comparison of four chemotherapy
regimens for advanced non-small-cell lung cancer. N Engl J Med.
346:92–98. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koski GK, Cohen PA, Roses RE, Xu S and
Czerniecki BJ: Reengineering dendritic cell-based anti-cancer
vaccines. Immunol Rev. 222:256–276. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie S, Wu X, Zhang G, Xu K, Bian X, Zhang
S and Ye Y: Remarkable regression of a lung recurrence from an
undifferentiated embryonal sarcoma of the liver treated with a DC
vaccine combined with immune cells: A case report. Cell Immunol.
290:185–189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao P, Bu X, Wei X, Sun W, Xie X, Li C,
Guo Q, Zhu D, Wei X and Gao D: Dendritic cell immunotherapy
combined with cytokine-induced killer cells promotes skewing toward
Th2 cytokine profile in patients with metastatic non-small cell
lung cancer. Int Immunopharmacol. 25:450–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shan CC, Shi LR, Ding MQ, Zhu YB, Li XD,
Xu B, Jiang JT and Wu CP: Cytokine-induced killer cells co-cultured
with dendritic cells loaded with the protein lysate produced by
radiofrequency ablation induce a specific antitumor response. Oncol
Lett. 9:1549–1556. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao M, Li H, Li L and Zhang Y: Effects of
a gemcitabine plus platinum regimen combined with a dendritic
cell-cytokine induced killer immunotherapy on recurrence and
survival rate of non-small cell lung cancer patients. Exp Ther Med.
7:1403–1407. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang L, Ren B, Li H, Yu J, Cao S, Hao X
and Ren X: Enhanced antitumor effects of DC-activated CIKs to
chemotherapy treatment in a single cohort of advanced
non-small-cell lung cancer patients. Cancer Immunol Immunother.
62:65–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tzivion G, Gupta VS, Kaplun L and Balan V:
14-3-3 proteins as potential oncogenes. Semin Cancer Biol.
16:203–213. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Neal CL and Yu D: 14-3-3ζ as a prognostic
marker and therapeutic target for cancer. Expert Opin Ther Targets.
14:1343–1354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao J, Meyerkord CL, Du Y, Khuri FR and
Fu H: 14-3-3 proteins as potential therapeutic targets. Semin Cell
Dev Biol. 22:705–712. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fan T, Li R, Todd NW, Qiu Q, Fang HB, Wang
H, Shen J, Zhao RY, Caraway NP, Katz RL, et al: Up-regulation of
14-3-3zeta in lung cancer and its implication as prognostic and
therapeutic target. Cancer Res. 67:7901–7906. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lowe SW, Cepero E and Evan G: Intrinsic
tumour suppression. Nature. 432:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zha J, Harada H, Yang E, Jockel J and
Korsmeyer SJ: Serine phosphorylation of death agonist BAD in
response to survival factor results in binding to 14-3-3 not
BCL-XL. Cell. 87:619–628. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
del Peso L, González-García M, Page C,
Herrera R and Nuñez G: Interleukin-3-induced phosphorylation of BAD
through the protein kinase Akt. Science. 278:687–689. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Manegold C, Vansteenkiste J, Cardenal F,
Schuette W, Woll PJ, Ulsperger E, Kerber A, Eckmayr J and von Pawel
J: Randomized phase II study of three doses of the integrin
inhibitor cilengitide versus docetaxel as second-line treatment for
patients with advanced non-small-cell lung cancer. Invest New
Drugs. 31:175–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou P, Liang P, Dong B, Yu X, Han Z and
Xu Y: Phase I clinical study of combination therapy with microwave
ablation and cellular immunotherapy in hepatocellular carcinoma.
Cancer Biol Ther. 11:450–456. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee WC, Wang HC, Hung CF, Huang PF, Lia CR
and Chen MF: Vaccination of advanced hepatocellular carcinoma
patients with tumor lysate-pulsed dendritic cells: A clinical
trial. J Immunother. 28:496–504. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu XP, Xu YH, Zhou J and Pan XF: A
clinical study evaluating dendritic and cytokine-induced killer
cells combined with concurrent radiochemotherapy for stage IIIB
non-small cell lung cancer. Genet Mol Res. 14:10228–10235. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cui Y, Yang X, Zhu W, Li J, Wu X and Pang
Y: Immune response, clinical outcome and safety of dendritic cell
vaccine in combination with cytokine-induced killer cell therapy in
cancer patients. Oncol Lett. 6:537–541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li QY, Shi Y, Huang DH, Yang T, Wang JH,
Yan GH, Wang HY, Tang XJ, Xiao CY, Zhang WJ, et al:
Cytokine-induced killer cells combined with dendritic cells
inhibited liver cancer cells. Int J Clin Exp Med. 8:5601–5610.
2015.PubMed/NCBI
|
|
25
|
Obsil T and Obsilova V: Structural basis
of 14-3-3 protein functions. Semin Cell Dev Biol. 22:663–672. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gardino AK and Yaffe MB: 14-3-3 proteins
as signaling integration points for cell cycle control and
apoptosis. Semin Cell Dev Biol. 22:688–695. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matta A, DeSouza LV, Ralhan R and Siu KW:
Small interfering RNA targeting 14-3-3ζ increases efficacy of
chemotherapeutic agents in head and neck cancer cells. Mol Cancer
Ther. 9:2676–2688. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Zhao J, Du Y, Park HR, Sun SY,
Bernal-Mizrachi L, Aitken A, Khuri FR and Fu H: Down-regulation of
14-3-3zeta suppresses anchorage-independent growth of lung cancer
cells through anoikis activation. Proc Natl Acad Sci USA.
105:162–167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rong F, Li W, Chen K, Li DM, Duan WM, Feng
YZ, Li F, Zhou XW, Fan SJ, Liu Y, et al: Knockdown of RhoGDIα
induces apoptosis and increases lung cancer cell chemosensitivity
to paclitaxel. Neoplasma. 59:541–550. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin HI, Lee YJ, Chen BF, Tsai MC, Lu JL,
Chou CJ and Jow GM: Involvement of Bcl-2 family, cytochrome c and
caspase 3 in induction of apoptosis by beauvericin in human
non-small cell lung cancer cells. Cancer Lett. 230:248–259. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bishopric NH, Andreka P, Slepak T and
Webster KA: Molecular mechanisms of apoptosis in the cardiac
myocyte. Curr Opin Pharmacol. 1:141–150. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kavitha K, Kowshik J, Kishore TK, Baba AB
and Nagini S: Astaxanthin inhibits NF-κB and Wnt/β-catenin
signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to
induce intrinsic apoptosis in a hamster model of oral cancer.
Biochim Biophys Acta. 1830:4433–4444. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim MR, Jeong EG, Chae B, Lee JW, Soung
YH, Nam SW, Lee JY, Yoo NJ and Lee SH: Pro-apoptotic PUMA and
anti-apoptotic phospho-BAD are highly expressed in colorectal
carcinomas. Dig Dis Sci. 52:2751–2756. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jeong EG and Lee SH, Kim SS, Ahn CH, Yoo
NJ and Lee SH: Immunohistochemical analysis of phospho-BAD protein
and mutational analysis of BAD gene in gastric carcinomas. APMIS.
115:976–981. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zippo A, Serafini R, Rocchigiani M,
Pennacchini S, Krepelova A and Oliviero S: Histone crosstalk
between H3S10ph and H4K16ac generates a histone code that mediates
transcription elongation. Cell. 138:1122–1136. 2009. View Article : Google Scholar : PubMed/NCBI
|
